Patrys USED to be a clinical stage company with strong research and development going on in Germany. Now that they have announced PAT-SM6 is going nowhere at present (and its future looks bleak), PAT-SC1 is only preclinical (let's remember there is no manufacturing process in place yet for this product) and so milestones and royalty payments are years away even inChina, PAT-LM1 also sits on the shelf, they have announced there is no CAR-T programme and there has been no news on anything else from the pipeline for ages.
So the question is......what exactly are they doing from a clinical / scientific perspective? Nothing seems to be the answer?
What is happening to the German research team?
Seems then that there is a team of management in Melbourne pulling in big salaries but not doing anything to advance the pipeline or generate new IP that has value?????
Having cash is good but spending it on themselves is definately NOT good!
Ann: Market Update, page-41
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |